Skip to main content
Subscribe
  • Login
  • My Account
  • Logout
  • Register For Free
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HLTH 2024
    • Sponsored Content: Vital Signs Blog
  • Opinion
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Healthcare Marketing Impact Awards
    • Innovators Awards
    • Diversity Leaders
    • Leading Women
    • Best in Business Awards
    • The 2030 Playbook Conference
    • Innovations in Patient Experience
    • Leading Women Conference & Awards Luncheon
    • Leadership Summit
    • Workforce Summit
    • Best Places to Work Awards Gala
    • Diversity Leaders Gala
    • - Looking Ahead to 2025
    • - Financial Growth
    • - Hospital of the Future
    • - Value Based Care
    • - Looking Ahead to 2026
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Skilled Nursing Facilities
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
    • Sponsored Content
MENU
Breadcrumb
  1. Home
  2. Government
May 31, 2012 12:00 AM

Drug industry was at center of reform dealing, GOP investigators say

Rich Daly
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    Among all health industry groups with which the White House was negotiating deals leading up to passage of the 2010 healthcare law, drugmakers were seen by Washington Democrats as the key group, according to a yearlong investigation by House Republican staff (PDF).

    The details of the still-murky deal between health industry groups and Democrats leading up to enactment of the law has been the subject of an investigation by Energy and Commerce Committee Republicans. They sifted correspondence between White House officials, congressional Democrats and industry representatives to flesh out the details of the deal to support enactment of the healthcare overhaul in exchange for a role in crafting the legislation.

    The negotiations ultimately produced a May 2009 agreement by the Pharmaceutical Research and Manufacturers of America, Advanced Medical Technology Association, the American Hospital Association, the American Medical Association, America's Health Insurance Plans, and the Service Employees International Union to cut $2 trillion from the growth rate of national healthcare spending over 10 years.

    “Of these negotiations, the deal with PhRMA was the most carefully orchestrated, with extensive communications between top PhRMA officials and key White House personnel,” stated a May 31 letter to committee Republicans from the staff sifting through records related to the healthcare deals.

    White House negotiators, such as Nancy-Ann DeParle, then the president's senior healthcare adviser, had sought an agreement from drugmakers to accept $100 billion worth of reduced payments over 10 years, according to investigators. However, e-mails showed that when the drug industry balked, the White House accepted $80 billion in cuts, mainly through increased Medicaid rebates and paying for half of the cost of drugs in the so-called Medicare doughnut hole.

    “PhRMA also had direct input into the actual legislative policies that produced the $80 billion, including the proposal for closing the Part D doughnut hole,” according to the Republican memo.

    In exchange for the cuts, in part, the administration agreed to block enactment of policies opposed by the pharmaceutical industry, according to investigators.

    In response to the Republican investigation, Matthew Bennett, senior vice president for PhRMA, issued a written statement that his group had a long history of advocating for policies that ensure patient access to innovative medicines and foster medical progress.

    “Before, during and since the healthcare reform debate, PhRMA engaged with Congress and the Administration to advance these priorities,” he said. “The biopharmaceutical sector collaborates with a wide variety of stakeholders, including physician organizations, provider groups and consumer and patient advocates, to pursue the shared, bipartisan goal of improving patient access to high-quality health care coverage, services and treatments. We look forward to ongoing work with Congress and the Administration on bipartisan policy solutions that improve patient health.”

    Democrats said the deal-making outlined by the Republican investigation was both the latest example of a long legislative tradition undertaken by presidents of both parties before enactment of major laws and inaccurate in some important details.

    For example, the conclusion that PhRMA agreed to only $80 billion in payment reductions was significantly less than the amounts included in the final legislation, said a joint statement by Reps. Henry Waxman, ranking member of the committee, and Diana DeGette, ranking member of its Oversight Subcommittee.

    “Interviews the Committee staff conducted with PhRMA lobbyists reveal that the final legislation will cost the drug companies $110 to $125 billion,” the Democrats wrote. “This is substantially more than the amount the Republican memorandum says the White House was able to obtain.”

    The committee is next expected to study another aspect of the deal-making leading up to the law's enactment in which the drug industry allegedly agreed to undertake an advertising campaign to sway public opinion in favor of the law.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Legal-government-0225
    HHS lawsuit by Democratic AGs aims to stop restructuring, layoffs
    GettyImages-654573744.jpg
    Federal watchdog to retract medical debt collection opinion
    Most Popular
    1
    'Legendary' Hemsley takes over at UnitedHealth amid rough seas
    2
    Big retail tried to disrupt healthcare—who is making a dent?
    3
    These are the regulations the AHA wants RFK Jr. to scrap
    4
    Downside risk, upside payment highlight new CMS innovation agenda
    5
    Medicaid cuts bill clears key House committee
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2025. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HLTH 2024
      • Sponsored Content: Vital Signs Blog
    • Opinion
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Healthcare Marketing Impact Awards
        • Innovators Awards
        • Diversity Leaders
        • Leading Women
        • Best in Business Awards
      • Conferences
        • The 2030 Playbook Conference
        • Innovations in Patient Experience
        • Leading Women Conference & Awards Luncheon
        • Leadership Summit
        • Workforce Summit
      • Galas
        • Best Places to Work Awards Gala
        • Diversity Leaders Gala
      • Virtual Briefings
        • - Looking Ahead to 2025
        • - Financial Growth
        • - Hospital of the Future
        • - Value Based Care
        • - Looking Ahead to 2026
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Skilled Nursing Facilities
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing
      • Sponsored Content